GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells.
about
The gut hormones in appetite regulationGlucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferationThe physiological role of the brain GLP-1 system in stressHuman duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.Glucagon-like peptide 1 receptor plays a critical role in geniposide-regulated insulin secretion in INS-1 cellsRole and development of GLP-1 receptor agonists in the management of diabetes.Prevention and Reversal of Diabetes by All-Trans Retinoid Acid and Exendin-4 in NOD Mice.Glucagon-like peptide-1 increases beta-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression.Glial cell line-derived neurotrophic factor enhances neurogenin3 gene expression and beta-cell proliferation in the developing mouse pancreas.Transferrin fusion technology: a novel approach to prolonging biological half-life of insulinotropic peptidesActivation of the Reg family genes by pancreatic-specific IGF-I gene deficiency and after streptozotocin-induced diabetes in mouse pancreasThe effects of sleeve gastrectomy on hormonal regulation of glucose metabolism in Goto-Kakizaki rats.Diabetes and cardiovascular disease: the potential benefit of incretin-based therapiesThe role of incretins in glucose homeostasis and diabetes treatment.Activation of the GLP-1 receptor signalling pathway: a relevant strategy to repair a deficient beta-cell massNeuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic ratsAn extract of Artemisia dracunculus L. stimulates insulin secretion from β cells, activates AMPK and suppresses inflammationGlucagon-like peptide 1 agonists and the development and growth of pancreatic beta-cells.Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways.Self-assembling glucagon-like peptide 1-mimetic peptide amphiphiles for enhanced activity and proliferation of insulin-secreting cellsLixisenatide accelerates restoration of normoglycemia and improves human beta-cell function and survival in diabetic immunodeficient NOD-scid IL-2rg(null) RIP-DTR mice engrafted with human islets.Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD miceThe cardiovascular effects of GLP-1 receptor agonists.Exendin-4 enhances expression of Neurod1 and Glut2 in insulin-producing cells derived from mouse embryonic stem cells.Liraglutide: a once-daily GLP-1 analogue for the treatment of type 2 diabetes mellitus.Antidiabetic effect and mode of action of cytopiloyneHerbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compoundsStromal cell derived factor-1alpha protects stem cell derived insulin-producing cells from glucotoxicity under high glucose conditions in-vitro and ameliorates drug induced diabetes in ratsThe incretin hormone glucagon-like peptide 1 increases mitral cell excitability by decreasing conductance of a voltage-dependent potassium channel.Incretin-based therapies in type 2 diabetes mellitus.Clinical potential of lixisenatide once daily treatment for type 2 diabetes mellitusTherapeutic Strategies to Increase Human β-Cell Growth and Proliferation by Regulating mTOR and GSK-3/β-Catenin Pathways.Improved function and proliferation of adult human beta cells engrafted in diabetic immunodeficient NOD-scid IL2rγ(null) mice treated with alogliptin.Alleviating Effects of Baechu Kimchi Added Ecklonia cava on Postprandial Hyperglycemia in Diabetic Mice.The p21-activated kinase (PAK1) is involved in diet-induced beta cell mass expansion and survival in mice and human islets.Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection.The emerging role of the intestine in metabolic diseases.Possible role of GLP-1 and its agonists in the treatment of type 1 diabetes mellitus.Obesity and appetite controlRole of CCN5 (WNT1 inducible signaling pathway protein 2) in pancreatic islets.
P2860
Q21296779-7CEFDBB4-C0F2-47C7-B319-EC5956E40DC4Q24307581-5AED4B95-B340-413E-95C8-A048E23145ADQ28077787-22D25D8B-98D2-4287-929D-11BACB37D3D3Q33225025-F18E01FB-6944-4C92-95AE-4E9B4C2821CDQ33567322-669A4029-8710-4DC2-B9C6-EF7137E3B4B7Q33635830-CF37F063-7AC1-481D-AA3A-1677A10D0BEFQ33786943-BFD3EBC4-D2B3-405D-BF49-E1DEB2D15493Q33796119-07881923-B9E1-4B9A-9B56-F1D79724E27CQ33994768-C47BF91C-2150-45A7-8511-B99D0D674CDFQ34128861-63A0CF13-F5F7-4988-9F2D-9CB47CBD88B3Q34179807-423CD7DC-5B1A-4C8E-BA42-C13B23727A67Q34468600-769902EF-0B34-46E8-8AC5-72FC12489306Q34716791-61EBAAE6-C396-48B6-A61A-8623C67B8E07Q34901533-E4B92C91-EF51-40C4-8466-1D52133935C7Q35055522-14BA0E8E-5ADC-49E4-B4BE-70B06DA812E1Q35564256-38E1367E-6F8F-422E-A950-D966D7AD87EFQ35751915-5686CF28-EFBC-40C3-9690-62D2741800E1Q35772023-9C416E6C-45E3-44A4-B0C6-04621E71C736Q35778740-A96C5A81-95FA-4A36-9777-99A2D36D0D39Q35857021-A13FA09E-8B78-4284-8FAF-F62F8E9E1093Q35994230-1A7C96B9-0571-46B3-ADDE-E9A106E8AB60Q36228938-DE1C6D6A-30F0-4B31-84D7-8A6DE9712C0BQ36368998-260AE1B3-40B3-421F-9FCB-F39AC7A95FBBQ36582408-68CEA641-0120-478C-A06C-96E47C973619Q36715772-899B9D40-A98C-4421-8A31-7C5A0ADD20E4Q36723068-EC282975-ACE9-4091-B04E-3328EC5A34B1Q36801780-4948860C-0E42-4983-8B04-FD59AB55EF1CQ36863430-CD5556CE-BBAC-4865-B41A-95155C5ABB0AQ36897100-FB3FD426-160A-4A15-B825-061939B82818Q36964866-1FFE2E8B-ABE5-45DD-B244-964894B8DD68Q36972371-C9661FE6-CFD0-4B72-A772-EE9BC29F7974Q37377618-1407BB11-F2EC-4840-9A9E-3F47DADAE5DEQ37396692-CF8A9A72-400C-4BA7-976D-4E0D0B4ED49DQ37481485-44144E92-0B45-4069-A2B6-20DABAC864BFQ37606940-23DE83F5-47FA-46F2-8A71-4F3FD4A17970Q37686556-B234ABA3-4ADB-47F6-AD76-865636633E35Q37889275-E5A72049-540F-4847-93A5-EBDE3C091AFAQ38024321-A3CF4197-5D94-4445-B1E0-B29ECF1D5E8EQ38035293-6C24D9AB-464F-47FF-AD28-0135DF16F85EQ38730332-8C52F6F4-EA9C-4A13-962B-E64DEC8707C7
P2860
GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
GLP-1 receptor agonists are gr ...... r pancreatic islet beta cells.
@ast
GLP-1 receptor agonists are gr ...... r pancreatic islet beta cells.
@en
type
label
GLP-1 receptor agonists are gr ...... r pancreatic islet beta cells.
@ast
GLP-1 receptor agonists are gr ...... r pancreatic islet beta cells.
@en
prefLabel
GLP-1 receptor agonists are gr ...... r pancreatic islet beta cells.
@ast
GLP-1 receptor agonists are gr ...... r pancreatic islet beta cells.
@en
P356
P1476
GLP-1 receptor agonists are gr ...... or pancreatic islet beta cells
@en
P2093
Angela Bulotta
Riccardo Perfetti
P304
P356
10.1002/DMRR.357
P577
2003-03-01T00:00:00Z